The Journal of Rheumatology · 2009 · 98 citations · 28 references
MedicineNutritionCalcium HomeostasisHuman NutritionMicronutrient DeficiencyCalcium DeficiencyVitamin DVitamin D DeficiencyVitamin D MetabolismVitamin SupplementationDisease Activity MeasurementSerum 25-Hydroxyvitamin D StatusSerum Calcium MeasurementVitamin D AssessmentVitamin D BiomarkersVitamin D InsufficiencyVitamin Deficiencies
OBJECTIVE: To investigate 25-OH vitamin D concentrations in 2 independent systemic sclerosis (SSc) populations from France and Italy. METHODS: We studied 156 consecutive SSc patients comparable for demographic characteristics: 90 from Northern France and 66 from Southern Italy. 25-OH vitamin D, intact parathyroid hormone, and serum total calcium and phosphorus were measured in all patients. Vitamin D concentrations < 30 ng/ml were considered insufficiency, while values < 10 ng/ml were classified as deficiency. RESULTS: Vitamin D insufficiency and deficiency rates were very high and comparable between the 2 populations: 74/90 (82%) versus 57/66 (86%) for insufficiency and 29/90 (32%) versus 15/66 (23%) for deficiency, respectively, in the French and Italian patients. They were not influenced by vitamin D supplementation, which was not statistically different in the 2 groups. In the combined populations, a significant negative correlation was found between low vitamin D levels and European Disease Activity Score (p = 0.04, r = -0.17) and an even more significant correlation was found with acute-phase reactants (p = 0.004, r = -0.23 for erythrocyte sedimentation rate), and low levels of vitamin D were associated with the systolic pulmonary artery pressure (sPAP) estimated by echocardiography (p = 0.004). In multivariate analysis, vitamin D deficiency was associated with sPAP (p = 0.02). CONCLUSION: Vitamin D deficiency was very common in the 2 SSc populations, independent of geographic origin and vitamin D supplementation. This suggests that common vitamin D supplementation does not correct the deficiency in SSc patients, and that a higher dose is probably needed, especially in those with high inflammatory activity or severe disease.
28
Scleroderma (systemic sclerosis): classification, subsets and pathogenesis
E. Carwile LeRoy, Casilda G. Black, Raúl Fleischmajer et al. · 2001 · 4K citations
Medicine, Pathobiology, Pathology +10
Intake of vitamin D and risk of type 1 diabetes: a birth-cohort study
Elina Hyppönen, Esa Läärä, Antti Reunanen et al. · The Lancet · 2001 · 1.9K citations
Serum 25-Hydroxyvitamin D Levels and Risk of Multiple Sclerosis
Kassandra L. Munger, Lynn I. Levin, Bruce W. Hollis et al. · JAMA · 2006 · 1.9K citations
Life Sciences, Nutritional Sciences, Micronutrient Deficiency +13
Ann R. Webb, Loren Kline, Michael F. Holick · The Journal of Clinical Endocrinology & Metabolism · 1988 · 1.7K citations
Prevalence of Vitamin D Insufficiency in an Adult Normal Population
M C Chapuy, Paul Preziosi, M. Maamer et al. · Osteoporosis International · 1997 · 1.5K citations
Medicine, Nutrition, Human Nutrition +12